- Home
- A-Z Publications
- Mini Reviews in Medicinal Chemistry
- Previous Issues
- Volume 21, Issue 11, 2021
Mini Reviews in Medicinal Chemistry - Volume 21, Issue 11, 2021
Volume 21, Issue 11, 2021
-
-
Synthesis and Biological Properties of some New Lead Sulphonamide and Carboxamide Scaffolds Bearing Coumarin Moieties
Coumarin, sulphonamide, and amide scaffolds exhibit diverse pharmacological features and constitute an important class of therapeutic agents. In this review, we have discussed the synthesis, biological properties, and SAR of coumarins containing sulphonamide or amide group in the last seven years. Many reviews on the therapeutic activities of coumarins, sulphonamides, and amides have been published. Hence the authors foc Read More
-
-
-
The Therapeutic Potential of Purinergic Receptors in Alzheimer’s Disease and Promising Therapeutic Modulators
Authors: Lili Pan, Yu Ma, Yunchun Li, Haoxing Wu, Rui Huang, Zhengxin Cai and Xiaoai WuRecent studies have proven that the purinergic signaling pathway plays a key role in neurotransmission and neuromodulation, and is involved in various neurodegenerative diseases and psychiatric disorders. With the characterization of the subtypes of receptors in purinergic signaling, i.e. the P1 (adenosine), P2X (ion channel) and P2Y (G protein-coupled), more attention has been paid to the pathophysiology and therapeutic po Read More
-
-
-
A Brief Introduction to Porphyrin Compounds used in Tumor Imaging and Therapies
Authors: Lili Pan, Yu Ma, Xiaoai Wu, Huawei Cai, Feng Qin, Haoxing Wu, Yun C. Li and Zhiyun JiaAs a group of heterocyclic macrocycle organic natural compounds occurring universally in animal tissues and plants, porphyrins are composed of four modified pyrrole subunits. Porphyrin analogues/ derivatives possess multiple biochemical properties because of their unique structures and have been extensively investigated in cancer treatment. Studies have shown that porphyrins and their derivatives have the ability to loc Read More
-
-
-
SHP2 Inhibition Benefits Epidermal Growth Factor Receptor-mutated Non-Small Cell Lung Cancer Therapy
Authors: Leiming Xia, Lu Wen and Siying WangEGFR-TKIs are confronted with big challenge of everlasting activated EGFR mutations which lack effective binding sites; this barrier is the dark side that largely limits the outcome of NSCLC patients in the clinic. Combination strategies show impressive anti-tumor efficacy that compared with EGFR-TKI mono-treatment, especially targeting both stem cells and non-stem cells. SHP2 (Src homology 2-containing phosphotyrosine p Read More
-
-
-
An Update on Extemporaneous Preparation of Radiopharmaceuticals Using Freeze-Dried Cold Kits
More LessThe field of nuclear medicine is rapidly evolving due to the high demand of radiopharmaceuticals for diagnostic and therapeutic applications. The availability of a vast array of radioisotopes, improvement in radiolabeling strategies, and advancements in detection systems have also contributed to the progress in this field. Radiopharmaceuticals are mainly classified based on their application as diagnostic or therapeutic radiophar Read More
-
-
-
Nucleoside and Non-Nucleoside DOT1L Inhibitors: Dawn of MLLrearranged Leukemia
Authors: Meng Cao, Tong Li, Yuxiang Chen and Xin ZhaiHerein, the underlying role of disruptor of telomeric silencing 1-like (DOT1L) as a therapeutic target for mixed-lineage leukemia (MLL)-rearranged is comprehensively clarified. DOT1L can be aberrantly recruited by an MLL fusion partner, thereby causing the over-expression, of several leukemia relevant genes and eventually leading to leukemia. As the unique histone methyltransferase (HMT), DOT1L possesses the function to spe Read More
-
-
-
Interaction of Dehydrogenase Enzymes with Nanoparticles in Industrial and Medical Applications, and the Associated Challenges: A Mini-review
Authors: Samaneh J. Porzani, Adriana S. Lorenzi, Masoumeh Eghtedari and Bahareh NowruziBackground: Nanoparticles (NPs) are a group of particles with at least one dimension ranging from 1 nm to 100 nm in diameter and a surrounding interfacial layer. The NP-protein interactions include covalent and non-covalent bonds. Several dehydrogenase enzymes (e.g., alcohol dehydrogenase, lactate dehydrogenase, alanine dehydrogenase, glutamate dehydrogenase, leucine dehydrogenase, phenylalanine deh Read More
-
-
-
Recent Applications of Benzimidazole as a Privileged Scaffold in Drug Discovery
Authors: Yongzhen Guo, Xuben Hou and Hao FangBenzimidazole is an aromatic bicyclic heterocycle that is regarded as a valuable privileged scaffold in medicinal chemistry. Many marketed drugs and natural products containing benzimidazole scaffolds exert great influence in fighting various diseases, such as hypertension, peptic ulcers, parasitic infections, and cancer. In this review, we introduce the pharmacological applications of some marketed drugs and lead compo Read More
-
-
-
Imidazole Derivatives and their Antibacterial Activity - A Mini-Review
Authors: Gâz Şerban Andrei, Boda F. Andrei and Pop Rahela RoxanaBackground: The development of drug resistance by bacterial strains is a public health issue, being the main cause of the decrease in the effectiveness of numerous antibiotics. In this context, it is essential to find new drugs with better antibacterial activity. Objective: The authors proposed to cover relevant literature, published following the review article written by Rani et al., illustrating chemical structures and an Read More
-
Volumes & issues
-
Volume 25 (2025)
-
Volume 24 (2024)
-
Volume 23 (2023)
-
Volume 22 (2022)
-
Volume 21 (2021)
-
Volume 20 (2020)
-
Volume 19 (2019)
-
Volume 18 (2018)
-
Volume 17 (2017)
-
Volume 16 (2016)
-
Volume 15 (2015)
-
Volume 14 (2014)
-
Volume 13 (2013)
-
Volume 12 (2012)
-
Volume 11 (2011)
-
Volume 10 (2010)
-
Volume 9 (2009)
-
Volume 8 (2008)
-
Volume 7 (2007)
-
Volume 6 (2006)
-
Volume 5 (2005)
-
Volume 4 (2004)
-
Volume 3 (2003)
-
Volume 2 (2002)
-
Volume 1 (2001)
Most Read This Month
Article
content/journals/mrmc
Journal
10
5
false
en
